CN
首页 / EFS投资孵化业务 / 业务简介 /
In house developed GPCR cell lines are ready for distribution and assay screening services.
In-house developed crystal structures are ready for distribution, which can be used for compound soaking.
Viva is devoted to push the boundary of the GPCR protein studies. Working closely with experienced experts from GPCR field
Viva supported custom two antibody generation platforms: phage display screening and hybridoma antibody generation technologies.
In-house developed high quality proteins are ready for assays. Some of the crystalizable proteins can be used for crystal structure researches (compound soaking, compound co-crystallization).
关于“”
请与我们进一步联系
